El Khoury Daniel, Pardo Emmanuel, Cambriel Amelie, Bonnet Francis, Pham Tai, Cholley Bernard, Quesnel Christophe, Verdonk Franck
Department of Anaesthesiology and Intensive Care, Hôpital Saint-Antoine Assistance Publique des Hôpitaux de Paris and Sorbonne University, GRC 29, DMU DREAM, Paris, France.
Department of Intensive Care Medicine, Hôpital Kremlin Bicêtre Hospital and Paris Saclay University, Assistance Publique des Hôpitaux de Paris, Paris, France.
Crit Care Explor. 2023 Mar 20;5(3):e0882. doi: 10.1097/CCE.0000000000000882. eCollection 2023 Mar.
To evaluate the correlation between gastric cross-sectional area (GCSA) and the occurrence of gastric intolerance in critically ill patients within 24 hours of the measurement.
Two-center prospective observational study.
Two academic ICUs in France between June 2020 and August 2021.
All surgical intubated ICU patients greater than or equal to 18 years old receiving enteral feeding for greater than 12 hours.
None.
Forty-four patients were included, 11 (25%) of whom presented digestive intolerance. Primary outcome was assessment of the association between GCSA and the occurrence of gastric intolerance within 24 hours of the measurement. GCSA value was significantly higher in patients with upper digestive intolerance compared to those without (553 mm [interquartile range (IQR), 500-649 mm] vs 970 mm [IQR, 777-1,047]; < 0.001, respectively). The optimal threshold for predicting upper digestive intolerance was 720 mm (area under the receiver operating characteristic curve 0.86; positive predictive value 62.5%; negative predictive value 96.4%; sensibility 0.91; and specificity 0.81). Multivariate analysis (weighted by propensity score), including known risk factors, showed that GCSA above the 720 mm threshold was independently associated with the occurrence of upper digestive intolerance (odds ratio, 1.85; 1.37-2.49; < 0.0002). Measurement quality was "good" (i.e., liver, aorta, superior mesenteric vein, and pancreas were all visualized) in 81% of cases.
Measurement of GCSA by ultrasound would allow prediction of gastric intolerance in critically ill patients. This should be confirmed by a prospective score validation and interventional trials.
评估危重症患者在测量后24小时内胃横截面积(GCSA)与胃不耐受发生情况之间的相关性。
两中心前瞻性观察性研究。
2020年6月至2021年8月期间法国的两个学术重症监护病房。
所有年龄大于或等于18岁、接受肠内喂养超过12小时的外科插管重症监护病房患者。
无。
纳入44例患者,其中11例(25%)出现消化不耐受。主要结局是评估测量后24小时内GCSA与胃不耐受发生情况之间的关联。与无上部消化不耐受的患者相比,有上部消化不耐受的患者GCSA值显著更高(分别为553毫米[四分位间距(IQR),500 - 649毫米] vs 970毫米[IQR,777 - 1047毫米];P < 0.001)。预测上部消化不耐受的最佳阈值为720毫米(受试者工作特征曲线下面积为0.86;阳性预测值为62.5%;阴性预测值为96.4%;敏感度为0.91;特异度为0.81)。多因素分析(按倾向评分加权),包括已知危险因素,显示GCSA高于720毫米阈值与上部消化不耐受的发生独立相关(比值比,1.85;95%置信区间为1.37 - 2.49;P < 0.0002)。81%的病例测量质量为“良好”(即肝脏、主动脉、肠系膜上静脉和胰腺均清晰可见)。
通过超声测量GCSA可预测危重症患者的胃不耐受情况。这应通过前瞻性评分验证和干预性试验来证实。